Skip to main content
. 2016 Jul 28;7(34):55155–55168. doi: 10.18632/oncotarget.10894

Figure 2.

Figure 2

Association between (A) baseline THBS1 expression and overall survival; (B) baseline SPARC expression and overall survival; (C–E) α-SMA expression at baseline, cycle 1 and cycle 2 with progression-free survival; (F–H) α-SMA expression at baseline, cycle 1 and cycle 2 with overall survival; (I) baseline combined stromal protein expression score and overall survival; (J) baseline combined stromal protein expression score and progression-free survival.